赴美移民多种疫苗同时接种安全性的回顾性研究

[目的]探讨中国人群中用多种疫苗不同部位同时接种的安全性,为其进一步推广提供科学依据。[方法]对1999年1月-2006年9月到广东国际旅行卫生保健中心接受预防接种的赴美移民登记资料及2004年1月-2006年9月报告不良反应资料进行整理和统计分析。[结果]1999年1月-2006年9月,共有129903名赴美移民到中心接种各类疫苗436367针次,期间未出现1例严重异常反应。2004年1月-2006年9月,通过24h专线电话或现场报告共有80人发生不良反应,报告率为1．29％0,按接种针次计算为0．38％o。报告的不良反应以一般反应为主,占83．75％;0-6岁儿童不良反应报告率最高,为5．48％o。[结论]在中国各年龄段人群中同时进行多种疫苗（包括国产和进口）接种是安全可行的。     

综合治疗膝关节骨性关节炎144例疗效分析

膝关节骨性关节炎是中老年人常见的疾病,以膝关节疼痛、肿胀及关节活动障碍为特征,严重影响老年人的日常生活。我们于2005年1月～2007年3月对144例膝关节骨性关节炎患者进行了综合治疗,疗效满意,现介绍如下。     

糖尿病视网膜病变中医证候与西医分期的关系研究

【目的】研究糖尿病视网膜病变患者中医证候演变特征。【方法】对245例糖尿病视网膜病变患者不同分期的中医证候进行分析。【结果】经计数资料的相关分析表明，糖尿病视网膜病变的中医证候及其合并证候与病变的分期和病程均存在相关性（均P=0．0000）。①气阴两虚证、阴虚内热证、脾虚湿热证在亚临床期、单纯期分别占33．85％、33．00％、32．30％、25．00％、21．54％、26．00％；与同期脾虚痰湿证、阴阳两虚证相比较，差异有统计学意义（P〈0．05或P〈0．01）；在增殖期，气阴两虚证、脾虚痰湿证、阴阳两虚证分别占39．74％、26．92％、19．23％，与阴虚内热证、脾虚湿热证相比较，差异均有统计学意义（P〈0．05），阴阳两虚证在增殖期所占比例与单纯期、亚临床期比较，差异均有统计学意义（P〈0．05）；②病程在5年以下者，气虚证占85．48％为最多见，其次是阴虚证；病程在15年以上者，血瘀证型、痰湿证型达100％。【结论】糖尿病视网膜病变的中医证候在各期、各病程阶段是动态变化的。     

糖尿病视网膜病变辨证分型及其证候与易感基因的相关性研究

目的探讨糖尿病视网膜病变(diabetic retinopathy,DR)中医证型及其证型与亚甲基四氢叶酸还原酶(methylenetrahydrofolate reductase,MTHFR)基因、肾素血管紧张素Ⅰ转移酶(angiotensin Ⅰ-converting enzyme,ACE-1)基因多态性的相关性.方法用流行病学研究方法研究DR的主要临床证型;并用聚合链酶反应-限制性片段(polymerase chain reaction-restriction fragment length polymorphism,PCRRFLP)和聚合链酶反应(polymerase chain reaction,PCR)技术检测245例不同中医证型的MTHFR、ACE基因多态性.结果气阴两虚、阴虚内热、脾虚湿热、阴阳两虚、脾虚痰湿五证的合并证,占总例数的97.55%;DR患者阴阳两虚证、脾虚痰湿证组MTHFR基因的TT型基因频率和T等位基因的携带率较其它证型组明显增加,CC型基因频率和C等位基因携带率明显下降,ACE基因DD型基因频率和D等位基因的携带率明显增加、Ⅱ型基因频率和I等位基因携带率明显下降,差异均有显著性意义(P＜0.05,P＜0.01);而脾虚痰湿证与阴阳两虚证组比较,MTHFR、ACE基因各种基因型频率分布差异均无显著性(均P＞0.05).结论气阴两虚、阴虚内热、脾虚湿热、阴阳两虚、脾虚痰湿五证的合并证为DR的主要证型;阴阳两虚证组、脾虚痰湿证组与MTHFR基因C677T位点突变、ACE缺失型多态性表达密切相关.     

rhGM-CSF作为成人乙肝疫苗无(弱)应答者免疫佐剂初探

Objective To investigate the effect of recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) as adjuvant on immune response in adults of non-and hyporesponders to hepatitis B vaccine. Methods Those who were once immunized with recombined yeast gene hepatitis B vaccine more than one standard scheme in two years and negative for hepatitis B markers were randomly sorted as group A and group B. 33 adults of group A were given hepatitis B vaccine 10 μg each time. The immune procedure was O, 1 and 6month. 34 adults of group B were given rhGM-CSF 300 μg for the first day, then 10 μg each time for routine immune. The blood samples were collected before the first injection and in 1, 2 and 8 months (T1, T2, TS)following the first injection to test Anti-HBs. Results Anti-HBs positive conversion rates of group A and B at T8 was 39.39% and 64.71% respectively(P=0.038). Anti-HBs levels of group B at TI, T2, T8 were(113.85±198.56) mIU/ml, (312.40±349.44) mIU/ml, (427.74±411. 58) mIU/ml (P=0.001). There was significant difference between group A and B in T8 Anti-HBs levels(P=0.010). Conclusion Better immune response was found in the group of rhGM-CSF with hepatitis B vaccine. So rhGM-CSF can induce the immune respond to hepatitis B vaccine.     

rhGM-CSF作为成人乙肝疫苗无(弱)应答者免疫佐剂初探

Objective To investigate the effect of recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) as adjuvant on immune response in adults of non-and hyporesponders to hepatitis B vaccine. Methods Those who were once immunized with recombined yeast gene hepatitis B vaccine more than one standard scheme in two years and negative for hepatitis B markers were randomly sorted as group A and group B. 33 adults of group A were given hepatitis B vaccine 10 μg each time. The immune procedure was O, 1 and 6month. 34 adults of group B were given rhGM-CSF 300 μg for the first day, then 10 μg each time for routine immune. The blood samples were collected before the first injection and in 1, 2 and 8 months (T1, T2, TS)following the first injection to test Anti-HBs. Results Anti-HBs positive conversion rates of group A and B at T8 was 39.39% and 64.71% respectively(P=0.038). Anti-HBs levels of group B at TI, T2, T8 were(113.85±198.56) mIU/ml, (312.40±349.44) mIU/ml, (427.74±411. 58) mIU/ml (P=0.001). There was significant difference between group A and B in T8 Anti-HBs levels(P=0.010). Conclusion Better immune response was found in the group of rhGM-CSF with hepatitis B vaccine. So rhGM-CSF can induce the immune respond to hepatitis B vaccine.     

rhGM-CSF作为成人乙肝疫苗无(弱)应答者免疫佐剂初探

Objective To investigate the effect of recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) as adjuvant on immune response in adults of non-and hyporesponders to hepatitis B vaccine. Methods Those who were once immunized with recombined yeast gene hepatitis B vaccine more than one standard scheme in two years and negative for hepatitis B markers were randomly sorted as group A and group B. 33 adults of group A were given hepatitis B vaccine 10 μg each time. The immune procedure was O, 1 and 6month. 34 adults of group B were given rhGM-CSF 300 μg for the first day, then 10 μg each time for routine immune. The blood samples were collected before the first injection and in 1, 2 and 8 months (T1, T2, TS)following the first injection to test Anti-HBs. Results Anti-HBs positive conversion rates of group A and B at T8 was 39.39% and 64.71% respectively(P=0.038). Anti-HBs levels of group B at TI, T2, T8 were(113.85±198.56) mIU/ml, (312.40±349.44) mIU/ml, (427.74±411. 58) mIU/ml (P=0.001). There was significant difference between group A and B in T8 Anti-HBs levels(P=0.010). Conclusion Better immune response was found in the group of rhGM-CSF with hepatitis B vaccine. So rhGM-CSF can induce the immune respond to hepatitis B vaccine.     

rhGM-CSF作为成人乙肝疫苗无(弱)应答者免疫佐剂初探

Objective To investigate the effect of recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) as adjuvant on immune response in adults of non-and hyporesponders to hepatitis B vaccine. Methods Those who were once immunized with recombined yeast gene hepatitis B vaccine more than one standard scheme in two years and negative for hepatitis B markers were randomly sorted as group A and group B. 33 adults of group A were given hepatitis B vaccine 10 μg each time. The immune procedure was O, 1 and 6month. 34 adults of group B were given rhGM-CSF 300 μg for the first day, then 10 μg each time for routine immune. The blood samples were collected before the first injection and in 1, 2 and 8 months (T1, T2, TS)following the first injection to test Anti-HBs. Results Anti-HBs positive conversion rates of group A and B at T8 was 39.39% and 64.71% respectively(P=0.038). Anti-HBs levels of group B at TI, T2, T8 were(113.85±198.56) mIU/ml, (312.40±349.44) mIU/ml, (427.74±411. 58) mIU/ml (P=0.001). There was significant difference between group A and B in T8 Anti-HBs levels(P=0.010). Conclusion Better immune response was found in the group of rhGM-CSF with hepatitis B vaccine. So rhGM-CSF can induce the immune respond to hepatitis B vaccine.     

A Combined TCM Treatment for 72 Cases of Bony Gonitis

In recent years, we have treated 72 cases of bony gonitis with a combined TCM treatment by joint-irrigation, Chinese herbal medication and Tui Na massotherapy, and have obtained satisfactory therapeutic results. A report follows.     

功能锻炼疗法作用机制研究进展

功能锻炼是祖国医学治疗骨折的重要手段之一。通过肌肉的舒缩不但能保持骨折端的良好位置,矫正残余成角及侧方移位;同时还能对断面施加生理性的应力刺激,促进血液循环,增强组织代谢,保持肢体功能,调整骨的应力分布,提高愈合质量和速度。本文复习近10年来的有关文献,就功能锻炼疗法作用机制的研究进展做一综述。